Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Current Assets (2016 - 2025)

Sanofi (SNY) has disclosed Current Assets for 11 consecutive years, with $36.0 billion as the latest value for Q4 2025.

  • Quarterly Current Assets fell 20.83% to $36.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.0 billion through Dec 2025, down 20.83% year-over-year, with the annual reading at $35.0 billion for FY2025, 24.13% down from the prior year.
  • Current Assets hit $36.0 billion in Q4 2025 for Sanofi, down from $45.5 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $45.5 billion in Q4 2024 to a low of -$102.5 billion in Q4 2021.
  • Historically, Current Assets has averaged $9.4 billion across 5 years, with a median of $34.8 billion in 2022.
  • Biggest five-year swings in Current Assets: surged 133.96% in 2022 and later fell 20.83% in 2025.
  • Year by year, Current Assets stood at -$102.5 billion in 2021, then soared by 133.96% to $34.8 billion in 2022, then dropped by 5.18% to $33.0 billion in 2023, then skyrocketed by 37.91% to $45.5 billion in 2024, then decreased by 20.83% to $36.0 billion in 2025.
  • Business Quant data shows Current Assets for SNY at $36.0 billion in Q4 2025, $45.5 billion in Q4 2024, and $33.0 billion in Q4 2023.